通化金马：有关公司新药琥珀八氢氨吖啶片上市申请审评中的重大节点信息，均会在指定信息披露媒体发布

Group 1 - The company, Tonghua Golden Horse, has indicated that it will disclose significant information regarding the review of its new drug, Amber Dihydroaminoacridine Tablets, through designated information disclosure media [2] - Investors are advised to pay attention to the company's announcements for updates on the drug's market application review process [2]